Growth Metrics

Terns Pharmaceuticals (TERN) Long-Term Debt Issuances (2022 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $169000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Long-Term Debt Issuances rose 42.02% year-over-year to $169000.0, compared with a TTM value of $288000.0 through Dec 2023, up 142.02%, and an annual FY2023 reading of $410000.0, up 68.72% over the prior year.
  • Long-Term Debt Issuances was $169000.0 for Q4 2023 at Terns Pharmaceuticals, up from $119000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $169000.0 in Q4 2023 and bottomed at $119000.0 in Q4 2022.